Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13161499 | 0.97 | HSD17B10 (0.41) | HSD17B10KEAP1NFE2L2EPHX1KMT2A | |
| SCHEMBL15887292 | 0.89 | ALDH1A1 (0.41) | HSD17B10KEAP1NFE2L2EPHX1KMT2A | |
| SCHEMBL17403434 | 0.89 | KDM4E (0.39) | HSD17B10KEAP1NFE2L2EPHX1KMT2A | |
| SCHEMBL2616818 | 0.88 | — | — | |
| SCHEMBL260170 | 0.86 | KDM4E (0.40) | HSD17B10KEAP1NFE2L2KMT2AALDH1A1 | |
| SCHEMBL12688267 | 0.82 | EPHX1 (0.39) | HSD17B10KEAP1NFE2L2EPHX1KMT2A | |
| SCHEMBL15491602 | 0.82 | KMT2A (0.46) | HSD17B10KEAP1NFE2L2KMT2ARECQL | |
| SCHEMBL19172568 | 0.81 | KEAP1 (0.47) | HSD17B10KEAP1NFE2L2EPHX1KMT2A | |
| SCHEMBL13236970 | 0.80 | HSD17B10 (0.33) | HSD17B10KEAP1NFE2L2 | |
| SCHEMBL17758509 | 0.80 | HSD17B10 (0.33) | HSD17B10KEAP1NFE2L2MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160002557-A1 | PROCESS FOR PREPARING A UREA GREASE | SHELL OIL COMPANY | 2016-01-07 | — | — | US | disclosed |
| US-8304570-B2 | Prepolymer for biomedical materials | OUYANG YUN LIANG (TW) | 2012-11-06 | — | — | US | disclosed |
| US-20100286428-A1 | PREPOLYMER FOR BIOMEDICAL MATERIALS | OUYANG YUN LIANG | 2010-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286428-A1 | PREPOLYMER FOR BIOMEDICAL MATERIALS | ALG3, MATR3, COL1A1 | HSD17B10 2806/4885KEAP1 3091/4885NFE2L2 3084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.